» Articles » PMID: 8809758

YopH of Yersinia Pseudotuberculosis Interrupts Early Phosphotyrosine Signalling Associated with Phagocytosis

Overview
Journal Mol Microbiol
Date 1996 Jun 1
PMID 8809758
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The PTPase YopH of Yersinia is essential to the ability of these bacteria to block phagocytosis. Wild-type Yersinia pseudotuberculosis, but not the yopH mutant strain, resisted phagocytosis by J774 cells. Ingestion of a yopH mutant was dependent on tyrosine kinase activity. Transcomplementation with wild-type yopH restored the anti-phagocytic effect, whereas introduction of the gene encoding the catalytically inactive yopHC403A was without effect. The PTPase inhibitor orthovanadate impaired the anti-phagocytic effect of the wild-type strain, further demonstrating the importance of bacteria-derived PTPase activity for this event. The ability to resist phagocytosis indicates that the effect of the bacterium is immediately exerted when it becomes associated with the phagocyte. Within 30 s after the onset of infection, wild-type Y. pseudotuberculosis caused a YopH-dependent dephosphorylation of phosphotyrosine proteins in J774 cells. Furthermore, interaction of the cells with phagocytosable strains led to a rapid and transient increase in tyrosine phosphorylation of paxillin and some other proteins, an event dependent on the presence of the bacterial surface-located protein invasin. Co-infection with the phagocytosable strain and the wild-type strain abolished the induction of tyrosine phosphorylation. Taken together, the present findings demonstrate an immediate YopH-mediated dephosphorylation of macrophage phosphotyrosine proteins, suggesting that this PTPase acts by preventing early phagocytosis-linked signalling in the phagocyte.

Citing Articles

Citric Acid Controls the Activity of YopH Bacterial Tyrosine Phosphatase.

Styszko J, Kostrzewa T, Gorska-Ponikowska M, Kuban-Jankowska A Drug Des Devel Ther. 2024; 18:1165-1174.

PMID: 38623566 PMC: 11018125. DOI: 10.2147/DDDT.S444500.


Pathogenicity and virulence of .

Seabaugh J, Anderson D Virulence. 2024; 15(1):2316439.

PMID: 38389313 PMC: 10896167. DOI: 10.1080/21505594.2024.2316439.


Host-directed therapy for bacterial infections -Modulation of the phagolysosome pathway.

Taya T, Teruyama F, Gojo S Front Immunol. 2023; 14:1227467.

PMID: 37841276 PMC: 10570837. DOI: 10.3389/fimmu.2023.1227467.


Type III-Secreted Effectors Evade the Caspase-4 Inflammasome in Human Cells.

Zhang J, Brodsky I, Shin S bioRxiv. 2023; .

PMID: 36747770 PMC: 9900831. DOI: 10.1101/2023.01.24.525473.


Yersinia pseudotuberculosis YopE prevents uptake by M cells and instigates M cell extrusion in human ileal enteroid-derived monolayers.

Fasciano A, Dasanayake G, Estes M, Zachos N, Breault D, Isberg R Gut Microbes. 2021; 13(1):1988390.

PMID: 34793276 PMC: 8604394. DOI: 10.1080/19490976.2021.1988390.